Aleafia Health Inc.
ALEAF
$0.00
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 74.51% | 14.30% | 6.65% | 8.46% | -28.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.51% | 14.30% | 6.65% | 8.46% | -28.66% |
| Cost of Revenue | 1,421.63% | -26.36% | -148.49% | 137.98% | -85.12% |
| Gross Profit | -142.69% | 42.90% | 3,179.95% | -32.25% | 83.63% |
| SG&A Expenses | -1.42% | -44.73% | -32.46% | -53.73% | -38.05% |
| Depreciation & Amortization | -86.47% | -37.25% | -22.18% | -71.43% | 39.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 94.11% | -30.34% | -92.40% | -24.81% | -43.66% |
| Operating Income | -125.50% | 43.08% | 191.24% | 93.18% | 57.85% |
| Income Before Tax | -199.95% | 67.37% | 108.18% | -182.21% | 200.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -205.27% | 67.37% | 108.47% | -182.21% | 195.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -205.27% | 67.37% | 108.47% | -182.21% | 195.30% |
| EBIT | -125.50% | 43.08% | 191.24% | 93.18% | 57.85% |
| EBITDA | -358.46% | 39.88% | 244.99% | 146.43% | 73.52% |
| EPS Basic | -182.46% | 73.22% | 106.95% | -179.07% | 193.38% |
| Normalized Basic EPS | -46.15% | 51.21% | 147.70% | 55.00% | 50.00% |
| EPS Diluted | -182.46% | 73.22% | 106.95% | -179.07% | 193.38% |
| Normalized Diluted EPS | -46.15% | 51.21% | 147.70% | 55.00% | 50.00% |
| Average Basic Shares Outstanding | 27.46% | 21.76% | 21.76% | 4.04% | 2.17% |
| Average Diluted Shares Outstanding | 27.46% | 21.76% | 21.76% | 4.04% | 2.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
